Heroin

Overview

Heroin is described in the document as a semi-synthetic opioid, chemically processed from morphine, which is naturally found in the opium poppy. It enters the brain quickly, producing an immediate and intense effect, making it a highly addictive narcotic analgesic. Heroin appears in various forms: white powder, brown powder, or black tar heroin, which is a sticky, dark substance.

The drug is commonly known by multiple street names, including Dope, H, Smack, Junk, Horse, Scag, Brown, and Unga. Due to its rapid central nervous system (CNS) entry, heroin causes powerful euphoria followed by sedation, leading to very high dependence potential.

Heroin testing is performed for forensic purposes, workplace screening, sports-related investigations, pre-employment checks, post-accident testing, probation monitoring, and assessing compliance during drug-abuse treatment programs. The document outlines several testing methods, including LC-MS/MS, GC-MS, HPLC-MS, CE-MS, spectrophotometry, chromatography techniques, immunoassays, and ELISA.

Heroin presence can be detected in urine, blood, hair, and saliva, each with specific cutoff levels to determine positive results.

Symptoms

The document lists clear signs of heroin abuse, many of which reflect the drug’s depressant and neurological effects:

1. Paranoia or irrational suspicion
2. Agitation and panic
3. Delirium
4. Difficulty breathing
5. Slurred or slowed speech
6. Small or dilated pupils
7. Irregular heart rhythms and fluctuating blood pressure
8. Nausea and vomiting
9. Drowsiness and lethargy
10. Flushed skin
11. Runny nose
12. Sudden mood swings
13. Social withdrawal
14. Presence of needles or syringes
15. Constipation
16. Itching
17. Insomnia
18. Involuntary leg movements

The clinical significance notes further explain that heroin abuse can cause pinpoint pupils, altered mental status, respiratory depression, and eventually dependence and withdrawal symptoms. Withdrawal may include sweating, agitation, cramps, and irritability.

Causes

Heroin abuse and its related complications stem from several causes outlined in the document:

Pharmacological Causes

1. Heroin rapidly enters the CNS, causing immediate euphoria and reinforcing addictive behavior.
2. It suppresses respiratory function, a major cause of fatal overdose.
3. The drug alters mental status, producing effects ranging from drowsiness to coma.

Behavioral and Social Causes

1. Recreational misuse due to intense euphoria.
2. Peer influence and easy availability of street formulations.
3. Self-medication for pain, emotional stress, or trauma.

Diagnostic and Laboratory Causes

1. Need for testing during forensic cases, legal investigations, and workplace screening.
2. Detection driven by suspected intoxication or compliance monitoring during treatment.
3. Metabolic variability may affect detection windows and influence test results.

Heroin injection also leads to secondary issues such as contaminated needles, increasing risks of infections and cardiovascular complications.

Risk Factors

The document identifies a combination of biological, environmental, and testing-related risk factors:

Health-Related Risk Factors

1. Dependence and tolerance, requiring progressively higher doses.
2. Respiratory depression, the leading cause of heroin-related deaths.
3. Infectious complications, including HIV and hepatitis B/C, from needle sharing.
4. Skin and soft tissue infections, such as abscesses and cellulitis, from IV use.
5. Cardiovascular risks, including endocarditis from contaminated injections.
6. Pulmonary issues, including non-cardiogenic pulmonary edema during overdose.
7. Renal complications, such as rhabdomyolysis-associated acute kidney injury.

Testing and Diagnostic Risk Factors

1. Technical errors or interfering substances can lead to false results.
2. Adulterants like bleach can produce incorrect findings.
3. Diluted or substituted urine may create false negatives.
4. Negative results may occur even when drug levels are below the cutoff.
5. Variability in metabolism affects detection and interpretation.

Clinical Risk Factors

1. Heroin’s rapid CNS entry increases addiction potential.
2. Overdose risk rises with dependence and tolerance.
3. Naloxone responsiveness confirms opioid involvement but does not eliminate risk.

Prevention

Prevention focuses on safe testing practices, early detection, and preventing misuse.

Prevention of Misuse

1. Awareness programs addressing the dangers of heroin addiction.
2. Reducing access to street drugs and unsafe paraphernalia.
3. Encouraging early intervention for individuals showing behavioral changes.

Prevention During Testing

1. Using clean, sterile containers to prevent contamination or tampering.
2. Collecting 3.0 ml blood in the recommended EDTA tube when necessary.
3. Proper collection of urine, saliva, and hair samples based on standardized methods.
4. Ensuring timely transport to the laboratory.
5. Confirmatory testing with GC/MS for accurate results.

Clinical and Public Health Prevention

1. Monitoring abstinence during rehabilitation.
2. Encouraging harm-reduction strategies, including access to clean equipment.
3. Educating patients on overdose risks and withdrawal symptoms.
4. Timely use of naloxone during suspected opioid toxicity.